Labcyte Inc. invented and commercialized the ability to transfer liquids using sound waves. This truly revolutionary technology allows for unparalleled precision and accuracy in moving liquids in increments as low as a billionth of a liter. Since acoustic dispensing eliminates the need for pipettes (the traditional way to move liquids) it has been adopted by all 20 of the top 20 pharmaceutical firms, as it enables significant advances in the drug discovery process. Better quality data are generated by removing the variety of problems caused by tips (inaccuracy, clogging, and cross-contamination.) New drugs have been discovered and patents obtained solely due to the use of the Labcyte EchoŽ liquid handler. At the same time, costs are reduced and throughput is increased by reducing via miniaturization the use of expensive reagents or rare samples.
The Labcyte system has resulted in researchers achieving dramatic improvements in diagnostics and more broadly throughout all areas of life sciences. As a result, biotechnology, genomic services, diagnostic, synthetic biology and other firms, academic groups and contract research organizations are using Labcyte equipment around the world. The system is also being used as a critical part of setting up the testing for which drugs might be the most effective for treating leukemia patients on an individualized basis. This ability generates true precision medicine; treatments are tailored to individuals by first observing how a patient`s cells responds to drugs. While the Labcyte system is complex, sophisticated software makes is simple to operate. The company has also developed automation systems using robotics to streamline standard steps in life science research.
Acoustic dispensing will become the backbone for hundreds of applications in life sciences.